Skip to main content

2 Result(s)

within Ulrich Kube Remove this filter

and

  1. Article

    Open Access

    Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study

    Data are limited regarding routine use of everolimus after initial vascular endothelial growth factor (VEGF)–targeted therapy. The aim of this prospective, noninterventional, observational study was to assess ...

    Lothar Bergmann, Ulrich Kube, Christian Doehn, Thomas Steiner… in BMC Cancer (2015)

    Download PDF (1026 KB) View Article

  2. No Access

    Article

    Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis

    Renal cell carcinoma (RCC) is the most common renal tumor and accounts for nearly 3 % of adult cancers. In the recent years, seven new targeted agents have been approved changing the treatment in metastatic R...

    Luise Maute, Viktor Grünwald… in Journal of Cancer Research and Clinical On… (2014)